Although evidence of T-cell defects, either as cutaneous anergy, impaired response to T-cell mitogens, or decreased in vitro IL-2 production, has been observed in several single-case reports (2, 62) in-depth investigations of blood T-cell populations in GS patients have not been carried out in a systematic way. The gene discussed is IL2; the disease is Gerstmann syndrome.